EUCTR2006-000837-36-SE进行中(未招募)不适用
Effect of Naltrexone on cue-induced craving for Amphetamine in amphetamine dependent individuals
Beroendecentrum Stockholm0 个研究点开始时间: 2006年4月10日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1) Men between the ages 20-45 years
- •2) Fulfils DSM IV diagnosis for amphetamine dependence
- •3) Consumed amphetamine for minimum of 12 times in the 12 weeks
- •4) Drug free 2-7 days
- •5) Abstinent from nicotine and caffeine during the testing day
- •6) Permanent home address in Stockholm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Fulfils DSM IV diagnosis of any other substance dependence disorder (except nicotine)
- •2) Fulfils DSM IV diagnosis of any major psychological or psychiatric illness.
- •3) Traces of cannabis, opiates, cocaine, central amines or benzodiazepines in the urine at the day of testing and between the 2 testing days
- •4) Traces of alcohol as measured by breathalyser on the days of testing and between the 2 testing days
- •5) Presence of any serious somatic disorder (example, hypertension, arteriosclerosis, cirrhosis of the liver and hyperthyroidism)
- •6) Liver enzyme levels (for e.g., AST, ALT, GT) more than 3 times the normal levels
- •7) Regular use of medication that may confound the effects of the medication (e.g., pain killers, anti-depressants, psychoactive medication)
- •8) Renal insufficiency
- •9) Any previous experience with naltrexone
- •10) Known hypersensitivity to naltrexone
- •11) Participation as research subjects in clinical trial in the last 6 months.
研究者
相似试验
尚未招募
4 期
To compare the anti-craving effect of three drugs Naltrexone, Topiramate and Baclofen in patients using alcohol.CTRI/2019/05/019346SGT University
已完成
不适用
Effect of Naltrexone (Drug) in Patients With Cirrhosis with alcohol problem.CTRI/2020/05/025417Institute of Liver and Biliary Sciences100
已完成
不适用
The effect of Naltrexone, an Opiate Receptor Antagonist, on capsaicin dose-response in male Healthy volunteers (NORAH)ISRCTN35917266South Manchester University Hospital (UK)20
进行中(未招募)
不适用
The Effect of Naltrexone in Amphetamine Dependence: A Study using Functional Magnetic Resonance ImagingEUCTR2010-021384-33-SEBeroendecentrum Stockholm
已完成
3 期
Study of the efficacy of naltrexone on positive and negative symptoms in schizophrenic patientsSchizophrenia.SchizophreniaIRCT201110093010N4Kermanshah University of Medical Sciences30
